Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations

DOI: 10.1186/s40814-018-0327-z

Keywords: Immunoglobulin, COPD, COPD exacerbation, Pilot study, Randomized clinical trial, Feasibility and safety

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s40814-018-0327-z) contains supplementary material, which is available to authorized users

Full-Text